Gensight Biologics SA Stock Chart

Gensight Biologics SA (LSE) · Health Technology. stock live price and technical analysis view. Follow LSE data on Alerta Chart.

Checking data access...

About Gensight Biologics SA

LSE
Market Cap
27.46M
Shares Out.
173.15M
Sector
Health Technology
Industry
Pharmaceuticals: Major

GenSight Biologics SA is a clinical-stage gene therapy company, which engages in research and development of novel therapies for mitochondrial and neurodegenerative diseases of the eye. It also focuses on central nervous system diseases. The company was founded by Bernard Jacques Alex Gilly, Botond Roska, Jean Bennett, Connie Cepko, Luk H. Vandenberghe, Serge Picaud and Jose-Alain Sahel in 2012 and is headquartered in Paris, France.

www.gensight-biologics.com

Related Markets

Market Hub:Stocks Hub

Need more analysis tools?

With Alerta Chart Pro Terminal, you can follow 4 charts at the same time, see depth (order book) data and set 25 active alerts.

Start for Free
0RIM.GB (0RIM.GB) Stock Live Chart & Technical Analysis | Alerta Chart | Alerta Chart